Fibrate treatment and prevalence risk of mild hyperhomocysteinaemia in clinical coronary heart disease patients

Abstract

Fibrate treatment was associated with significant increase in prevalence risk of mild hyperhomocysteinemia in coronary patients, independently from conventional confounders.